View in browser

July 8, 2024

UC San Diego Health Introduces Innovative Gene Therapy for Bladder Cancer

A new FDA-approved bladder-saving gene therapy is the first of its kind to treat non-muscle-invasive bladder cancer. Moores Director Dr. Diane Simeone and MCC members Amirali Salmasi MD, MSCR and Aditya Bagrodia MD, FACS speak on the significant milestone for bladder cancer treatment.

READ MORE

Expanding Immunotherapy Efficacy by Understanding Mechanisms of Response Versus Resistance: Director’s Seminar Series 

On July 11, 2024 at 4:00 p.m., Thomas F. Gajewski, MD, PhD will present “Expanding Immunotherapy Efficacy by Understanding Mechanisms of Response Versus Resistance” for this session of the Distinguished Scientist Director's Seminar Series. 

RSVP NOW

Fighting COVID-19 With a Cancer Drug

In UC San Diego Today, Judith A. Varner PhD discusses how a molecule discovered twelve years ago to help cancer cells survive by shuttling damaging inflammatory cells into tumor tissue does the same thing in lung tissue infected with COVID-19 — the molecule can be suppressed with a repurposed cancer drug.

READ MORE

Cure Today Highlights Moores Member in “Oncologist Debunks Clinical Trial Myths”

Moores Member, Rebecca Shatsky MD debunks common clinical trial myths, the meaning of clinical trial phases, and how to know which clinical trial to enroll in. Understanding the truths of clinical trials is a crucial step in moving the needle in tomorrow’s treatments.   

READ MORE

UPCOMING EVENTS

 

CC WIP

Comparative Effectiveness of Implementation Strategies for Cervical Cancer Screening and Treatment for Women Living with HIV in Nigeria: The ACCESS Study

Gregory Aarons, PhD

July 10, 2024 | 12:00 p.m. to 1:00 p.m.

Moores Comer Commons and Zoom

STT SEMINAR

Novel Immunotherapy Targets: The Druggable Immune GPCRome and New Immune-Evasive Cancer Drivers

Silvio Gutkind, PhD

July 12, 2024 | 12:00 p.m. to 1:00 p.m.

Moores Comer Commons and Zoom

CBS Seminar

Transcriptional Control of CD8 T Cell Exhaustion in Cancer

Patrick G. Hogan, PhD

July 17, 2024 | 12:00 p.m. to 1:00 p.m.

Moores Comer Commons and Zoom

UCSD Symposium

Gene Therapy Initiative Symposium

September 19, 2024 | 8:30 a.m. to 6:30 p.m.

Duane Roth Auditorium (Sanford Consortium for Regenerative Medicine)

Testicular Cancer Awareness Foundation

Testicular Cancer Conference San Diego 2024

Timothy A. Masterson, MD and T. Clark Gamblin, MD, MS, MBA

September 19–21, 2024

Moores Goldberg Auditorium

View All Events

EDUCATION

 

The Scientific Translational and Experimental Postbaccalaureate in Oncology Program for Underrepresented Populations (STEPpOnUP) 

The STEPpOnUP strives to break down sociocultural barriers in healthcare by offering a unique opportunity to individuals from underserved backgrounds wishing to pursue doctoral level education in science, healthcare, and/or cancer (e.g., PhD, MD, etc.). Fellows will spend half of their time exploring the intricacies of cancer research in our Moores Cancer Center (MCC) laboratories, paired with one of our faculty members. The other half of their time, fellows will experience taking laboratory research from bench to bedside, working with our diverse patients through our Clinical Trials Office (CTO).

Learn More and Apply

FEATURED FUNDING OPPORTUNITIES

 

PAR-24-217 & PAR-24-218

NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Required or Basic Experimental Studies with Humans Required)

The purpose of this NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08) (Clinical Trials Required, PAR-24-217, or Basic Experimental Studies with Humans Required, PAR-24-218) is to support the career development of individuals with clinical doctoral degrees to create a group of new and well-trained, independent investigators. This supervised career development program will provide independent NIH research support during the early-career phase to help recipients establish independent research programs in areas supported by the NIH HEAL Initiative’s Clinical Research in Pain Management program.

 

This Notice of Funding Opportunity (NOFO) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development. 

 

Applicants not planning an independent clinical trial or basic experimental study with humans, or proposing to gain research experience in a clinical trial or basic experimental study with humans led by another investigator, must apply to the 'Independent Clinical Trial Not Allowed' companion NOFO (PAR-24-219).

PAR-24-217
Learn More and Apply
PAR-24-218
Learn More and Apply
See All Funding Opportunities

RECENT PUBLICATIONS

 

A pragmatic randomized trial of mailed fecal immunochemical testing to increase colorectal cancer screening among low-income and minoritized populations

Cancer

Maria Elena Martinez PhD (Cancer Control), Scott Roesch PhD (Cancer Control), Sheila F. Castaneda PhD (Cancer Control), Jesse Nodora DrPH (Cancer Control), Borsika A. Rabin PhD, MPH, PharmD (Cancer Control), Samir Gupta MD (Cancer Control)

A genome-wide CRISPR screen reveals that antagonism of glutamine metabolism sensitizes head and neck squamous cell carcinoma to ferroptotic cell death

Cancer Letter

Alfredo A. Molinolo MD, PhD (Solid Tumor Therapeutics), Prashant Mali PhD (Cancer Biology and Signaling), J. Silvio Gutkind PhD (Cancer Biology and Signaling)

Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost

International Journal of Radiation Oncology - Biology - Physics (IJROBP)

Dale M. Anders PhD (Solid Tumor Therapeutics), Rebecca A. Rakow-Penner MD, PhD (Solid Tumor Therapeutics), Tyler M. Seibert MD, PhD (Structural and Functional Genomics)

IL-10 suppresses T cell expansion while promoting tissue-resident memory cell formation during SARS-CoV-2 infection in rhesus macaques

PLoS Pathogens

Daniels Weiskopf PhD (Hematologic Malignancies), Alessandro D. Sette PhD (NPA)

COMMUNITY OUTREACH AND ENGAGEMENT

 
Placeholder Image

Community Health and Resource Fair at Jackie Robinson YMCA

This past Wednesday our COE team spoke to over 100 community members of Southeast San Diego at the community health and resource fair. We emphasized the need for early screening and encouraged them to stay informed and on top of their health. COE enjoys being a part of this recurring event every 1st Wednesday of the month at the Jackie Robinson YMCA!

Placeholder Image

Cancer Prevention 101 at Christie’s Place

The COE team delivered a Cancer Prevention 101 education session at Christie’s Place, followed by an engaging game night. This event combined vital health information with interactive fun, reinforcing key cancer prevention concepts for Christie’s Place clients. COE looks forward to collaborating with them in the future.

CAREERS

 
Placeholder Image
  • Network Coordinator II - Clinical Trials - 128248
  • Research Associate - 130888

Subscribe

About Us

Contact Us

Alternate Text logo

Department of Research Administration

3855 Health Sciences Drive, La Jolla, CA 92037

moorescancercenter.ucsd.edu

 

Unsubscribe | Privacy Policy | Submit Feedback